| Bioactivity | TCO-PEG4-VC-PAB-MMAE is a drug-linker conjugate for ADC. TCO-PEG4-VC-PAB-MMAE contains a cleavable ADC linker (TCO-PEG4-VC-PA) and a potent tubulin inhibitor MMAE (HY-15162)[1]. |
| Invitro | ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker. |
| Name | TCO-PEG4-VC-PAB-MMAE |
| CAS | 2758671-45-1 |
| Formula | C78H127N11O19 |
| Molar Mass | 1522.91 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | -20°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
TCO-PEG4-VC-PAB-MMAE
CAS: 2758671-45-1 F: C78H127N11O19 W: 1522.91
TCO-PEG4-VC-PAB-MMAE is a drug-linker conjugate for ADC. TCO-PEG4-VC-PAB-MMAE contains a cleavable ADC linker (TCO-PEG4-
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.